Latest Insider Transactions at Dyne Therapeutics, Inc. (DYN)
This section provides a real-time view of insider transactions for Dyne Therapeutics, Inc. (DYN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Dyne Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Dyne Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2021
|
Wildon Farwell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
|
Sep 21
2020
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
660,000
+19.05%
|
$12,540,000
$19.0 P/Share
|
|
Sep 21
2020
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,145,045
+50.0%
|
-
|
|
Sep 21
2020
|
Logos Global Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
700,000
+31.75%
|
$13,300,000
$19.0 P/Share
|
|
Sep 21
2020
|
Logos Global Management LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
804,392
+50.0%
|
-
|